Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD)

NCT01927705 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

NCT03252340 ·Status: COMPLETED

Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

NCT04137562 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic Dermatitis

NCT01232543 ·Status: COMPLETED ·Phase: PHASE2

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT06397911 ·Status: RECRUITING ·Phase: PHASE2

Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis

NCT02888704 ·Status: COMPLETED ·Phase: PHASE1

Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects

NCT02176551 ·Status: WITHDRAWN ·Phase: PHASE3

Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis

NCT04504279 ·Status: COMPLETED ·Phase: PHASE2

KM110329 in Adult Patients With Atopic Dermatitis

NCT01692093 ·Status: UNKNOWN ·Phase: PHASE2

Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects

NCT02176538 ·Status: WITHDRAWN ·Phase: PHASE3

Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis

NCT04283968 ·Status: UNKNOWN ·Phase: PHASE3

A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis

NCT03096223 ·Status: COMPLETED ·Phase: PHASE1

A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis

NCT07344051 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

NCT02087943 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis

NCT03747575 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis

NCT04179760 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy of Fecal Microbial Transplantation Treatment in Adults With Atopic Dermatitis

NCT04613037 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

NCT06947993 ·Status: RECRUITING ·Phase: PHASE2

Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study

NCT04936113 ·Status: TERMINATED ·Phase: PHASE2

A Clinical Study to Assess the Safety and Effectiveness of Test Products in Mild to Moderate Atopic Dermatitis (AD) Patients.

NCT06687512 ·Status: NOT_YET_RECRUITING ·Phase: NA

Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis

NCT04413942 ·Status: UNKNOWN ·Phase: PHASE2

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

NCT07217015 ·Status: RECRUITING ·Phase: PHASE2

Study to Determine the Pharmacokinetics of Product 0405

NCT02176577 ·Status: WITHDRAWN ·Phase: PHASE3

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

NCT04975438 ·Status: COMPLETED ·Phase: PHASE1

Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis

NCT02369432 ·Status: TERMINATED ·Phase: EARLY_PHASE1